Europe - BIT:1KVUE - US49177J1025 - Common Stock
The current stock price of 1KVUE.MI is 13.812 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
OR.PA | L'OREAL | 29.53 | 200.78B | ||
LOR.DE | L'OREAL | 29.53 | 200.78B | ||
UNA.AS | UNILEVER PLC | 22.58 | 124.01B | ||
UNVB.DE | UNILEVER PLC | 22.58 | 124.01B | ||
BEI.DE | BEIERSDORF AG | 23.7 | 21.96B | ||
COTY.PA | COTY INC-CL A | 17.9 | 2.97B | ||
ITP.PA | INTERPARFUMS SA | 16.43 | 2.41B | ||
ICOS.MI | INTERCOS SPA | 25.18 | 1.19B | ||
ONTEX.BR | ONTEX GROUP NV | 52.17 | 515.51M | ||
PHN.MI | PHARMANUTRA SPA | 19.61 | 465.12M | ||
ENV.MI | ENERVIT | 17.44 | 77.61M | ||
JBOG.PA | JACQUES BOGART | N/A | 50.21M |
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 22,000 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
KENVUE INC
1 Kenvue Way
Summit NEW JERSEY US
Employees: 22000
Phone: 19088741200
The current stock price of 1KVUE.MI is 13.812 EUR. The price decreased by -6.96% in the last trading session.
The exchange symbol of KENVUE INC is 1KVUE and it is listed on the Euronext Milan exchange.
1KVUE.MI stock is listed on the Euronext Milan exchange.
KENVUE INC (1KVUE.MI) has a market capitalization of 26.51B EUR. This makes 1KVUE.MI a Large Cap stock.
KENVUE INC (1KVUE.MI) currently has 22000 employees.
The Revenue of KENVUE INC (1KVUE.MI) is expected to decline by -2.77% in the next year. Check the estimates tab for more information on the 1KVUE.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
KENVUE INC (1KVUE.MI) has a dividend yield of 5.28%. The yearly dividend amount is currently 0.69. Check the full fundamental report for a detailed analysis of 1KVUE.MI dividend history, reliability and sustainability.
KENVUE INC (1KVUE.MI) will report earnings on 2025-10-23, before the market open.
The PE ratio for KENVUE INC (1KVUE.MI) is 15.18. This is based on the reported non-GAAP earnings per share of 0.91 and the current share price of 13.812 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1KVUE.MI.
ChartMill assigns a technical rating of 1 / 10 to 1KVUE.MI.
ChartMill assigns a fundamental rating of 3 / 10 to 1KVUE.MI. 1KVUE.MI has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months 1KVUE.MI reported a non-GAAP Earnings per Share(EPS) of 0.91. The EPS decreased by -12.3% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 9.37% | ||
ROA | 5.23% | ||
ROE | 13.22% | ||
Debt/Equity | 0.73 |
For the next year, analysts expect an EPS growth of -7.42% and a revenue growth -2.77% for 1KVUE.MI